Emmanuel Katsanis, MD

ekatsani@arizona.edu

I am a Professor of Pediatrics, Medicine, Immunobiology, Pathology and a member of the University of Arizona Cancer Center, Steele Children’s Research Center and the Bio5 Institute. I combine my expertise in the laboratory and the clinical arenas as the Director of the Hematopoietic Cellular Therapy and Transplant Program (adult and pediatric) and Division Chief of Pediatric Hematology/Oncology. I have 30+ years of research experience in the field of tumor and transplant immunology.

Cancer Focus

More recently my work has focused on immunomodulation with bendamustine following haploidentical-BMT. Additionally, my laboratory is studying pre-transplant modulation of host cells by selective agents and their effects on immune reconstitution, graft versus host disease and graft versus tumor effects. I designed and initiated an ongoing phase I/Ib clinical trial in haploidentical bone marrow transplantation based from our published preclinical work.

Research Program Role
Clinical and Translational Oncology Program

Display Name
Emmanuel Katsanis, MD

Publications

Graff RM, Kunz HE, Agha NH, Baker FL, Laughlin M, Bigley AB, Markofski MM, LaVoy EC, Katsanis E, Bond RA, et al. 2018. β-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans. Brain Behav Immun. 74:143–153. doi:10.1016/j.bbi.2018.08.017.